figure 2.
Kaplan-Meier curves of time to symptom improvement (days) by quartiles of area under the concentration-time curve (AUC) through 72 hours. The cumulative proportion of participants with all symptoms improved for 2 consecutive days was calculated using Kaplan-Meier methods for quartiles of AUC0-72h (area under the concentration-time curve from time 0 to 72 hours) for (A) BMS-986414 (C135-LS), (B) BMS-986413 (C144-LS), and (C) BMS-986414 (C135-LS) + BMS-986413 (C144-LS). Numbers above the x-axis indicate the number of participants still in follow-up who have not previously had 2 consecutive days with all targeted symptoms improved. The time to symptom improvement was compared between quartiles using the Gehan-Wilcoxon test.